microdosing glp 1 perimenopause Understanding GLP-1 Benefits for Symptoms Trends: from microdosing GLP 1-s
Description
Rather than targeting GLP-1 receptors alone, it's a dual agonist activating both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors simultaneously
However, stopping these medications often leads to regaining weight because they do not permanently change the bodys weight regulation
Therapie 67, 539543
Lin, Y., & Sun, Z
doi:10.1136/bmj.k872
The goal of this work is to provide comparisons between the different drugs used to treat type 2 diabetes
